https://www.selleckchem.com/pr....oducts/bsj-4-116.htm
006), and a 10m improvement on the incremental shuttle walk test was associated with a 3% reduced risk for death (p=.04). However, this relationship was not present in analysis adjusted for age, gender and eGFR. No association was seen between any factor for the development of ESRD or time to first hospitalization. These results suggest that in this small cohort, muscle size and exercise capacity are associated with mortality when considered alone, but this relationship was not present in adjusted analyses. Further investigation in a